![](https://www.oruen.com/wp-content/uploads/2019/06/Screenshot-2019-06-27-at-11.20.23-1024x570.png)
1) Keeping pace with advances in anticoagulation – Stephen Davis, Australia
2) What is the evidence for dabigatran? – Richard A. Bernstein, USA
3) What is the evidence for NOAC reversal strategies? – Sheila Martins, Brazil
4 How do we manage dabigatran and idarucizumab in neurological emergencies – Martin Grond, Germany
0 Comments